{"id":"W2055934966","doi":"10.3899/jrheum.130864","title":"The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial","year":2014,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Placebo; Rheumatoid arthritis; Quality of life (healthcare); Visual analogue scale; Physical therapy; Internal medicine; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002479203,0.001357061,0.002521476,0.0002848233,0.0003895561,0.0007237976,0.000632217,0.001407974,0.002741573],"category_scores_gemma":[0.001636393,0.0003232007,0.001554626,0.0002640527,0.0008674019,0.0005958328,0.0003028824,0.002201904,0.0005672211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004181771,"about_ca_system_score_gemma":0.000768398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004184651,"about_ca_topic_score_gemma":0.0008135499,"domain_scores_codex":[0.9993964,0.0003699849,0.00003040299,0.00005213399,0.00005726273,0.0000937132],"domain_scores_gemma":[0.998909,0.000365829,0.0002970919,0.00008465147,0.00006639714,0.0002769853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9185115,0.01487198,0.001588523,0.0008431033,0.001048202,0.0000850593,0.00008088011,0.0006511633,0.009159436,0.00008707933,0.00174572,0.05132729],"study_design_scores_gemma":[0.8461272,0.1467357,0.004599425,0.00005131819,0.000389652,0.00006233228,0.00001679658,0.0002912713,0.0009994502,0.00005794972,0.0006580145,0.00001093079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833052,0.01029323,0.0006938412,0.0008529035,0.0002374659,0.001874628,0.0010646,0.000124173,0.001553993],"genre_scores_gemma":[0.9855781,0.00482287,0.001656067,0.001258128,0.000517573,0.002619025,0.001584172,0.00003814446,0.001925868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002741573,"threshold_uncertainty_score":0.01311141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02093699614157634,"score_gpt":0.3111309162759551,"score_spread":0.2901939201343788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}